Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis

Jonathan Cooper; Qingwen Xu; Lu Zhou; Milica Pavlovic; Virginia Ojeda; Kamalika Moulick; Stanchina E de; John T. Poirier; Marjorie Zauderer; Charles M. Rudin; Matthias A. Karajannis; C. Oliver Hanemann; Filippo G. Giancotti

doi:10.1158/1535-7163.MCT-16-0821

Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis

Jonathan Cooper^*, Qingwen Xu, Lu Zhou, Milica Pavlovic, Virginia Ojeda, Kamalika Moulick, Stanchina E de, John T. Poirier, Marjorie Zauderer, Charles M. Rudin, Matthias A. Karajannis, C. Oliver Hanemann, Filippo G. Giancotti

^*Corresponding author for this work

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

16 Downloads (Pure)

Original language	English
Pages (from-to)	molcanther.0821.2016-molcanther.0821.2016
Number of pages	0
Journal	Molecular Cancer Therapeutics
Volume	0
Issue number	0
Early online date	3 May 2017
DOIs	https://doi.org/10.1158/1535-7163.MCT-16-0821
Publication status	Published - 3 May 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1535-7163.MCT-16-0821

10

Cite this

Cooper, J., Xu, Q., Zhou, L., Pavlovic, M., Ojeda, V., Moulick, K., de, S. E., Poirier, J. T., Zauderer, M., Rudin, C. M., Karajannis, M. A., Hanemann, C. O., & Giancotti, F. G. (2017). Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis. Molecular Cancer Therapeutics, 0(0), molcanther.0821.2016-molcanther.0821.2016. https://doi.org/10.1158/1535-7163.MCT-16-0821

@article{3c34fbabc39d4ea1829d4601589a1edd,

title = "Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis",

author = "Jonathan Cooper and Qingwen Xu and Lu Zhou and Milica Pavlovic and Virginia Ojeda and Kamalika Moulick and de, {Stanchina E} and Poirier, {John T.} and Marjorie Zauderer and Rudin, {Charles M.} and Karajannis, {Matthias A.} and Hanemann, {C. Oliver} and Giancotti, {Filippo G.}",

year = "2017",

month = may,

day = "3",

doi = "10.1158/1535-7163.MCT-16-0821",

language = "English",

volume = "0",

pages = "molcanther.0821.2016--molcanther.0821.2016",

journal = "Molecular Cancer Therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "0",

}

Cooper, J, Xu, Q, Zhou, L, Pavlovic, M, Ojeda, V, Moulick, K, de, SE, Poirier, JT, Zauderer, M, Rudin, CM, Karajannis, MA, Hanemann, CO & Giancotti, FG 2017, 'Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis', Molecular Cancer Therapeutics, vol. 0, no. 0, pp. molcanther.0821.2016-molcanther.0821.2016. https://doi.org/10.1158/1535-7163.MCT-16-0821

TY - JOUR

T1 - Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis

AU - Cooper, Jonathan

AU - Xu, Qingwen

AU - Zhou, Lu

AU - Pavlovic, Milica

AU - Ojeda, Virginia

AU - Moulick, Kamalika

AU - de, Stanchina E

AU - Poirier, John T.

AU - Zauderer, Marjorie

AU - Rudin, Charles M.

AU - Karajannis, Matthias A.

AU - Hanemann, C. Oliver

AU - Giancotti, Filippo G.

PY - 2017/5/3

Y1 - 2017/5/3

U2 - 10.1158/1535-7163.MCT-16-0821

DO - 10.1158/1535-7163.MCT-16-0821

M3 - Article

SN - 1535-7163

VL - 0

SP - molcanther.0821.2016-molcanther.0821.2016

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

IS - 0

ER -